# US 2003/0223980 A1 · Uses of thioredoxin

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0223980 A1
- Document ID: US20030223980A1
- Status: Published application
- Kind: A1
- Application number: 10/600,957
- Filed: 2003-06-20
- Published: 2003-12-04
- Earliest claimed: 1996-12-06
- Inventors: Garth Powis
- Web page: https://patentgrep.com/patent/US20030223980A1

## CPC

- A61K 38/44: Oxidoreductases (1)
- A61P 35/00: Antineoplastic agents
- G01N 33/5011: {for testing antineoplastic activity}
- G01N 33/573: for enzymes or isoenzymes
- A61K 48/00: Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- G01N 2333/90209: acting on NADH or NADPH (1.6), e.g. those with a heme protein as acceptor (1.6.2) (general), Cytochrome-b5 reductase (1.6.2.2) or NADPH-cytochrome P450 reductase (1.6.2.4)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention relates to the use of thioredoxin as, inter alia, a cell growth stimulator, as well as a screen for agents that are useful in reducing or preventing thioredoxin-associated apoptosis inhibition and agents that are useful in inhibiting thioredoxin stimulated cell growth.

## Claims

### Claim 1

A method of inhibiting tumor cell growth in a tumor cell that over-expresses thioredoxin comprising contacting said tumor cell with a cell growth inhibiting effective amount of an inhibitor of thioredoxin expression.

### Claim 2

A method of reducing inhibition of apoptosis in tumor cells that over-express thioredoxin comprising contacting said tumor cells with an effective amount of an agent that inhibits thioredoxin.

### Claim 3

A method of identifying an agent that inhibits tumor cell growth in cells that over-express thioredoxin comprising
measuring thioredoxin expression in a first sample of said cells;
contacting a second sample of said cells with an agent to be tested;
measuring expression of thioredoxin in said second sample;
comparing expression of thioredoxin in said first sample and said second sample;
whereby a decrease in expression of thioredoxin in said second sample is indicative of an agent that inhibits tumor cell growth.

### Claim 4

A method of identifying an agent that reduces inhibition of apoptosis in a tumor cell that over-expresses thioredoxin comprising
measuring thioredoxin expression in a first sample of said cells;
contacting a second sample of said cells with an agent to be tested;
measuring expression of thioredoxin in said second sample;
comparing expression of thioredoxin in said first sample and said second sample;
whereby a decrease in expression of thioredoxin in said second sample is indicative of an agent that reduces inhibition of apoptosis.

### Claim 5

A method of identifying an agent that reduces inhibition of apoptosis in a tumor cell growth.

### Claim 6

A method of stimulating cell growth comprising introducing a nucleic acid encoding a human thioredoxin having Ser at amino acid reside 73 under conditions whereby said nucleic acid is expressed.

### Claim 7

A composition comprising an agent that is useful in reducing or eliminating thioredoxin-associated apoptosis inhibition and an acceptable carrier.

### Claim 8

A composition comprising an agent that is useful in inhibiting thioredoxin stimulated cell growth and an acceptable carrier.
